Table 1.
Clinical characteristics of kidney transplant patients, (n = 450)
| Characteristics | N (%) |
|---|---|
| Age at transplantation (years) | 45 ± 13 |
| <60 | 377 (83.8) |
| ≥ 60 | 73 (16.2) |
| Gender | |
| Male | 293 (65.1) |
| Female | 157 (34.9 |
| Follow up time (months); median (range) | 38 (2-71) |
| Type of donor | |
| Live related donor | 192 (42.7) |
| Diseased donor | 258 (57.3) |
| Number of transplant | |
| First | 436 (96.9) |
| Second | 11 (2.4) |
| Third | 3 (0.7) |
| Induction agent | |
| Daclizumab | 237 (52.7) |
| Basiliximab | 176 (39.1) |
| Anti-thymocyte globulin | 23 (5.1) |
| None | 14 (3.1) |
| Death at last follow-up | |
| No | 439 (97.6) |
| Yes | 11 (2.4) |
| Graft functionality at death | |
| Unknown | 1 (9.1) |
| Graft in function | 8 (72.7) |
| Graft not in function | 2 (18.2) |
| Rejection | |
| No | 417 (92.6) |
| Yes | 33 (7.4) |
| Pre-transplant VZV disease | |
| No | 51 (11.3) |
| Yes | 201 (44.7) |
| Unknown | 198 (44) |